273 related articles for article (PubMed ID: 19218429)
1. CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth.
Augsten M; Hägglöf C; Olsson E; Stolz C; Tsagozis P; Levchenko T; Frederick MJ; Borg A; Micke P; Egevad L; Ostman A
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3414-9. PubMed ID: 19218429
[TBL] [Abstract][Full Text] [Related]
2. Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion.
Xin H; Cao Y; Shao ML; Zhang W; Zhang CB; Wang JT; Liang LC; Shao WW; Qi YL; Li Y; Zhang ZY; Yang Z; Sun YH; Zhang PX; Jia LL; Wang WQ
Int Urol Nephrol; 2018 May; 50(5):861-868. PubMed ID: 29524043
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties.
Augsten M; Sjöberg E; Frings O; Vorrink SU; Frijhoff J; Olsson E; Borg Å; Östman A
Cancer Res; 2014 Jun; 74(11):2999-3010. PubMed ID: 24710408
[TBL] [Abstract][Full Text] [Related]
4. A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer.
Sjöberg E; Meyrath M; Milde L; Herrera M; Lövrot J; Hägerstrand D; Frings O; Bartish M; Rolny C; Sonnhammer E; Chevigné A; Augsten M; Östman A
Clin Cancer Res; 2019 Jun; 25(12):3702-3717. PubMed ID: 30850359
[TBL] [Abstract][Full Text] [Related]
5. The roles of Y-box-binding protein (YB)-1 and C-X-C motif chemokine ligand 14 (CXCL14) in the progression of prostate cancer via extracellular-signal-regulated kinase (ERK) signaling.
Wang C; Zhao N; Sato F; Tanimoto K; Okada H; Liu Y; Bhawal UK
Bioengineered; 2021 Dec; 12(2):9128-9139. PubMed ID: 34696665
[TBL] [Abstract][Full Text] [Related]
6. Modulation of CXCL14 (BRAK) expression in prostate cancer.
Schwarze SR; Luo J; Isaacs WB; Jarrard DF
Prostate; 2005 Jun; 64(1):67-74. PubMed ID: 15651028
[TBL] [Abstract][Full Text] [Related]
7. Expression of CXCL14 and its anticancer role in breast cancer.
Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
[TBL] [Abstract][Full Text] [Related]
8. Exosomal CXCL14 Contributes to M2 Macrophage Polarization through NF-
Tian HY; Liang Q; Shi Z; Zhao H
Oxid Med Cell Longev; 2022; 2022():7616696. PubMed ID: 35669852
[TBL] [Abstract][Full Text] [Related]
9. The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.
Fazi B; Proserpio C; Galardi S; Annesi F; Cola M; Mangiola A; Michienzi A; Ciafrè SA
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117166
[TBL] [Abstract][Full Text] [Related]
10. Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer.
Sjöberg E; Augsten M; Bergh J; Jirström K; Östman A
Br J Cancer; 2016 May; 114(10):1117-24. PubMed ID: 27115465
[TBL] [Abstract][Full Text] [Related]
11. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
Orimo A; Gupta PB; Sgroi DC; Arenzana-Seisdedos F; Delaunay T; Naeem R; Carey VJ; Richardson AL; Weinberg RA
Cell; 2005 May; 121(3):335-48. PubMed ID: 15882617
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells.
Song EY; Shurin MR; Tourkova IL; Gutkin DW; Shurin GV
Cancer Res; 2010 Jun; 70(11):4394-401. PubMed ID: 20460540
[TBL] [Abstract][Full Text] [Related]
13. CXCL14 inhibits trophoblast outgrowth via a paracrine/autocrine manner during early pregnancy in mice.
Kuang H; Chen Q; Fan X; Zhang Y; Zhang L; Peng H; Cao Y; Duan E
J Cell Physiol; 2009 Nov; 221(2):448-57. PubMed ID: 19626669
[TBL] [Abstract][Full Text] [Related]
14. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.
Shurin GV; Ferris RL; Tourkova IL; Perez L; Lokshin A; Balkir L; Collins B; Chatta GS; Shurin MR
J Immunol; 2005 May; 174(9):5490-8. PubMed ID: 15843547
[TBL] [Abstract][Full Text] [Related]
15. CDX2 enhances natural killer cell-mediated immunotherapy against head and neck squamous cell carcinoma through up-regulating CXCL14.
Wang H; Nan S; Wang Y; Xu C
J Cell Mol Med; 2021 May; 25(10):4596-4607. PubMed ID: 33733587
[TBL] [Abstract][Full Text] [Related]
16. Expression of tumour-suppressing chemokine BRAK/CXCL14 reduces cell migration rate of HSC-3 tongue carcinoma cells and stimulates attachment to collagen and formation of elongated focal adhesions in vitro.
Sato K; Ozawa S; Izukuri K; Kato Y; Hata R
Cell Biol Int; 2010 Apr; 34(5):513-22. PubMed ID: 20067447
[TBL] [Abstract][Full Text] [Related]
17. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis.
Yang F; Tuxhorn JA; Ressler SJ; McAlhany SJ; Dang TD; Rowley DR
Cancer Res; 2005 Oct; 65(19):8887-95. PubMed ID: 16204060
[TBL] [Abstract][Full Text] [Related]
18. Chemokine CXCL14; a double-edged sword in cancer development.
Gowhari Shabgah A; Haleem Al-Qaim Z; Markov A; Valerievich Yumashev A; Ezzatifar F; Ahmadi M; Mohammad Gheibihayat S; Gholizadeh Navashenaq J
Int Immunopharmacol; 2021 Aug; 97():107681. PubMed ID: 33932697
[TBL] [Abstract][Full Text] [Related]
19. The cytokine gene CXCL14 restricts human trophoblast cell invasion by suppressing gelatinase activity.
Kuang H; Chen Q; Zhang Y; Zhang L; Peng H; Ning L; Cao Y; Duan E
Endocrinology; 2009 Dec; 150(12):5596-605. PubMed ID: 19833716
[TBL] [Abstract][Full Text] [Related]
20. Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis.
Bonfil RD; Chinni S; Fridman R; Kim HR; Cher ML
Urol Oncol; 2007; 25(5):407-11. PubMed ID: 17826661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
